Head-to-head · WeighScore
Alan Meds vs FormidableMD
By GLP-1 ScorecardUpdated
Score comparison
FormidableMD has the higher recorded score — 73.2/100 to 65.7/100.
FormidableMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormidableMD is a physician-led, cash-pay telehealth practice based in Florida offering GLP-1 weight-loss treatment — semaglutide and tirzepatide in both FDA-approved and compounded forms, plus oral options — alongside peptides, HRT/TRT, urgent care, labs, and nutrition coaching.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Alan Meds | FormidableMD |
|---|---|---|
| WeighScore | 65.7/100 | 73.2/100 |
| Grade | C | C |
| Site position | #238 | #80 |
| Semaglutide | $158/mo equivalent (2-month upfront promotion, compounded) | $169/mo (1 mg dose, compounded) |
| Tirzepatide | $325/mo equivalent (6-month upfront plan, compounded) | $199/mo (10 mg dose, compounded) |
| Coverage | Eligibility depends on state, prescription and pharmacy | 1 state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #238 · C
FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.
Strengths
- Advertised compounded injection pricing stays the same across doses
- Online care with a choice of injection and sublingual preparations
- Outside-pharmacy choice described; separate charges may apply
- Public catalog lists branded Wegovy and Zepbound options
What to consider
- Lowest compounded price labels require upfront multi-month payment
- First renewal may process early; cancel before the actual processing deadline
- Unused subscription periods are not refundable under the ordinary terms
- Rejection-refund promise differs from broader medical-consent wording
Site position #80 · C
Strengths
- Transparent, published dose-by-dose pricing for semaglutide ($169-$269/mo) and tirzepatide ($199-$319/mo) with no membership or commitment
- Offers both FDA-approved and compounded GLP-1s (plus oral options) from 503A pharmacies, with a real provider at every visit
- Boutique physician-led model bundling labs, peptides, HRT/TRT and urgent care; FSA/HSA eligible
What to consider
- Florida-focused telehealth — availability outside FL is not advertised, so out-of-state access is uncertain
- Medication cost is on top of a $199 initial consultation and $99 follow-up visits (pay-per-visit, not an all-in monthly price)
- The 503A compounding pharmacy partner is not named on the site
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.